Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS Stock
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Price Chart
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS Financial and Trading Overview
Contents
- Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Price Chart
- Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
- Q&A For Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Stock
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong stock price | 4.23 CNY |
Previous Close | 5.57 CNY |
Open | 5.55 CNY |
Bid | 5.52 CNY x 0 |
Ask | 5.53 CNY x 0 |
Day's Range | 5.5 - 5.56 CNY |
52 Week Range | 5.25 - 8.05 CNY |
Volume | 10.3M CNY |
Avg. Volume | 9.79M CNY |
Market Cap | 9.19B CNY |
Beta (5Y Monthly) | 0.377384 |
PE Ratio (TTM) | 12.021739 |
EPS (TTM) | 0.37 CNY |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 18, 2010 |
1y Target Est | 7.65 CNY |
600866.SS Valuation Measures
Enterprise Value | 12.57B CNY |
Trailing P/E | 12.021739 |
Forward P/E | 10.240741 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.52565783 |
Price/Book (mrq) | 1.3104267 |
Enterprise Value/Revenue | 0.719 |
Enterprise Value/EBITDA | 4.784 |
Trading Information
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Stock Price History
Beta (5Y Monthly) | 0.377384 |
52-Week Change | -12.42% |
S&P500 52-Week Change | 20.43% |
52 Week High | 8.05 CNY |
52 Week Low | 5.25 CNY |
50-Day Moving Average | 5.67 CNY |
200-Day Moving Average | 6.19 CNY |
600866.SS Share Statistics
Avg. Volume (3 month) | 9.79M CNY |
Avg. Daily Volume (10-Days) | 12.87M CNY |
Shares Outstanding | 1.66B |
Float | 596.1M |
Short Ratio | N/A |
% Held by Insiders | 67.33% |
% Held by Institutions | 1.56% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 135:100 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.12% |
Operating Margin (ttm) | 8.20% |
Gross Margin | 15.36% |
EBITDA Margin | 15.02% |
Management Effectiveness
Return on Assets (ttm) | 9.45% |
Return on Equity (ttm) | 20.73% |
Income Statement
Revenue (ttm) | 17.48B CNY |
Revenue Per Share (ttm) | 13.27 CNY |
Quarterly Revenue Growth (yoy) | -0.20% |
Gross Profit (ttm) | 3.09B CNY |
EBITDA | 2.63B CNY |
Net Income Avi to Common (ttm) | 545.79M CNY |
Diluted EPS (ttm) | 0.46 |
Quarterly Earnings Growth (yoy) | -34.20% |
Balance Sheet
Total Cash (mrq) | 1.42B CNY |
Total Cash Per Share (mrq) | 0.85 CNY |
Total Debt (mrq) | 4.4B CNY |
Total Debt/Equity (mrq) | 62.31 CNY |
Current Ratio (mrq) | 0.893 |
Book Value Per Share (mrq) | 4.22 |
Cash Flow Statement
Operating Cash Flow (ttm) | 844.56M CNY |
Levered Free Cash Flow (ttm) | 1.37B CNY |
Profile of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong
Country | China |
State | N/A |
City | Zhaoqing |
Address | No.67 Gongnong North Road |
ZIP | 526040 |
Phone | 86 75 8229 1130 |
Website | https://www.starlake.com.cn |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 8908 |
Star Lake Bioscience Co., Inc. manufactures and sells pharmaceutical raw materials, and food and feed additives in China and internationally. It offers guanosine that is used as an intermediate for food and pharmaceutical raw material; L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed. The company also provides disodium 5'-ribonucleotide to cure chronic hepatitis, muscular atrophy, and eye diseases; disodium 5-inosinate to cure leukopenia, thrombocytopenia, and chronic and acute hepatitis; and inosine, which is used for the treatment of chronic hepatitis, heart disease, leukopenia or thrombocytopenia, central choroidoretinitis, etc. In addition, the company offers disodium 5'-guanylate for canned meat, ham, salted meat, etc. Further, it provides ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-threonine, L-lysine, etc. The company offers its products under the Star Lake and Yue Bao brands. Star Lake Bioscience Co., Inc. was founded in 1964 and is based in Zhaoqing, China.
Q&A For Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Stock
What is a current 600866.SS stock price?
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 600866.SS stock price today per share is 4.23 CNY.
How to purchase Star Lake Bioscience Co., Inc.Zhaoqing Guangdong stock?
You can buy 600866.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Star Lake Bioscience Co., Inc.Zhaoqing Guangdong?
The stock symbol or ticker of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong is 600866.SS.
Which industry does the Star Lake Bioscience Co., Inc.Zhaoqing Guangdong company belong to?
The Star Lake Bioscience Co., Inc.Zhaoqing Guangdong industry is Biotechnology.
How many shares does Star Lake Bioscience Co., Inc.Zhaoqing Guangdong have in circulation?
The max supply of Star Lake Bioscience Co., Inc.Zhaoqing Guangdong shares is 1.66B.
What is Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Price to Earnings Ratio (PE Ratio)?
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong PE Ratio is 11.43243200 now.
What was Star Lake Bioscience Co., Inc.Zhaoqing Guangdong earnings per share over the trailing 12 months (TTM)?
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong EPS is 0.37 CNY over the trailing 12 months.
Which sector does the Star Lake Bioscience Co., Inc.Zhaoqing Guangdong company belong to?
The Star Lake Bioscience Co., Inc.Zhaoqing Guangdong sector is Healthcare.